Luye Pharma Group (HK:2186) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Luye Pharma Group has successfully completed the issuance of US$100 million in convertible bonds at a 5.85% interest rate, due in 2025. This move aims to enhance the company’s liquidity and replace short-term loans, improving its debt maturity profile. The bonds are set to be listed on the Singapore Exchange on November 1, 2024.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.